A drug or treatment (in this instance, the dengue vaccine) is given approval for general use after Phase III studies have been found conclusive by regulators. Since the vaccine is new, the objective of Phase IV studies is to obtain more information about its effects and any side effects with long-term use. Photo: AFP
The approval for use of the dengue vaccine is welcomed by clinicians as it is an additional measure to combat dengue, of which there have been more than 100,000 cases annually in the past three years.
Malaysia joined 14 other countries, including the Philippines, Indonesia, Singapore and Thailand in approving the use of this vaccine.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
